Mohammadi, Mahmoud http://orcid.org/0000-0003-2775-5019
IJzerman, Nikki S.
Hollander, Dide den
Bleckman, Roos F.
Oosten, Astrid W.
Desar, Ingrid M. E.
Reyners, An K. L.
Steeghs, Neeltje
Gelderblom, Hans
Funding for this research was provided by:
Novartis (3017/13)
Pfizer Pharmaceuticals (WI189378)
Bayer (2014-MED-12005)
Deciphera Pharmaceuticals (4EE9EEC-7F19-484D-86A4-646CFE0950A5)
Article History
Accepted: 19 March 2023
First Online: 20 April 2023
Declarations
:
: No external funding was used in the analysis and preparation of this manuscript. An unrestricted research grant for the DGR to NKI was received from Novartis (3017/13), Pfizer (WI189378), Bayer (2014-MED-12005), and Deciphera (4EE9EEC-7F19-484D-86A4-646CFE0950A5). These funding sources did not have any involvement in conducting this research.
: Mahmoud Mohammadi, Nikki S. IJzerman, Dide den Hollander, Roos F. Bleckman, Astrid W. Oosten, Ingrid M.E. Desar, An K. L. Reyners, Neeltje Steeghs and Hans Gelderblom declare they have no conflicts of interest that might be relevant to the contents of this manuscript.
: The local Medical Ethics Review Committee of LUMC confirmed that the Medical Research Involving Human Subjects Act did not apply for this study (registration no. G19.122).
: Not applicable.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Mahmoud Mohammadi: Conceptualization, formal analysis, writing—original draft, writing—review and editing. Nikki S. Ijzerman: Investigation, formal analysis, writing—review and editing. Dide den Hollander: Investigation, writing—review and editing. Roos F. Bleckman: Investigation, writing—review and editing. Astrid W. Oosten: Writing—review and editing. Ingrid M.E. Desar: Writing—review and editing. An K. L. Reyners: Writing—review and editing. Neeltje Steeghs: Methodology, writing—review and editing. Hans Gelderblom: Conceptualization, methodology, supervision.